Author:
Chughtai Bilal,Lee Richard,Hall Matthew,Te Alexis E.
Reference69 articles.
1. Roehrborn CG. Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell’s urology. 9th ed. Amsterdam: Elsevier.
2. Oishi K, Boyle P, Barry M. Epidemiology and natural history of benign prostatic hyperplasia. In: Fourth international consultation on benign prostatic hyperplasia. Plymouth: Plymbridge Distributors Ltd; 1998. p. 23.
3. Girman CJ. Natural history and epidemiology of benign prostatic hyperplasia: relationship among urologic measures. Urology. 1998;51:8.
4. Roehrborn CG. The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia. Int J Impot Res. 2008;20 Suppl 3:S19.
5. Bohnen AM, Groeneveld FP, Bosch JL. Serum prostate-specific antigen as a predictor of prostate volume in the community: the Krimpen study. Eur Urol. 2007;51:1645.